SCHEMBL4852346

SCHEMBL4852346

COc1ccc(C=CC(=O)c2cc(O)ccc2OCCN(C)C)c(OC)c1OC

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 2/20 0.63
ABCG2 Q9UNQ0 1/20 0.52
ALOX5 P09917 1/20 0.51
CYP1A1 P04798 2/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2D6 P10635 2/20 0.47
CYP1B1 Q16678 2/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
NR1H4 Q96RI1 2/20 0.47
LMNA P02545 1/20 0.47
TP53 P04637 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
ABCB1 P08183 1/20 0.46
MEN1 O00255 1/20 0.45
MAPT P10636 1/20 0.45
MAPK1 P28482 1/20 0.45
KMT2A Q03164 1/20 0.45
CAPN1 P07384 1/20 0.45
CTSL P07711 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4846198 1.00 CHRNA7 (0.63) CHRNA7ABCG2ALOX5CYP1A1CYP1A2
SCHEMBL4856277 0.90 CHRNA7 (0.54) CHRNA7ABCG2ALOX5CYP1A1CYP1A2
SCHEMBL4852824 0.90 CHRNA7 (0.54) CHRNA7ABCG2ALOX5CYP1A1CYP1A2
SCHEMBL4846217 0.88 CHRNA7 (0.58) CHRNA7ALOX5CYP1A1CYP1A2CYP1B1
SCHEMBL4853733 0.87 ABCG2 (0.54) CHRNA7ABCG2ALOX5CYP1A1CYP1A2
SCHEMBL4849381 0.87 ABCG2 (0.54) CHRNA7ABCG2ALOX5CYP1A1CYP1A2
SCHEMBL4845547 0.87 MCHR1 (0.49) CHRNA7ABCG2ALOX5CYP1A1CYP1A2
SCHEMBL4853032 0.87 MCHR1 (0.49) CHRNA7ABCG2ALOX5CYP1A1CYP1A2
SCHEMBL4855889 0.87 CHRNA7 (0.49) CHRNA7ABCG2ALOX5CYP1A1CYP1A2
SCHEMBL4857279 0.87 CHRNA7 (0.49) CHRNA7ABCG2ALOX5CYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
EP-1515940-A2 AMINOALKOXY-FUNCTIONAL CHALCONES Lica Pharmaceuticals A/S (DK) 2005-03-23 EP claimed
WO-2003097574-A2 AMINOALKOXY-FUNCTIONAL CHALCONES LICA PHARMACEUTICALS A/S (DK) 2003-11-27 WO claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed
EP-1515940-A2 AMINOALKOXY-FUNCTIONAL CHALCONES Lica Pharmaceuticals A/S (DK) 2005-03-23 EP disclosed
WO-2003097574-A2 AMINOALKOXY-FUNCTIONAL CHALCONES LICA PHARMACEUTICALS A/S (DK) 2003-11-27 WO disclosed